Soria Ester Banque
Insider
First SEC filing: July 7, 2026 · Latest: July 7, 2026
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 5, 2026 | MRNA | A | 38,364 | · | · | 38,364 Direct | · | Acquired | (price as of 2026-10-02) |
| July 5, 2026 | MRNA | A | 18,658 | · | · | 18,658 Direct | · | Acquired | (price as of 2026-10-02) |
| Oct. 4, 2024 | ZTS | A | 154 | $61.07 | $9,405 | 320 Direct | +92.77% | Acquired | 14.1% (price as of 2026-10-02) |
| July 31, 2024 | ZTS | M | 895 | · | · | 895 Direct | · | Acquired | (price as of 2026-10-02) |
| July 31, 2024 | ZTS | F | 307 | $180.04 | $55,272 | 588 Direct | -34.30% | Disposed | -61.3% (price as of 2026-10-02) |
| July 31, 2024 | ZTS | M | 895 | · | · | 1,790 Direct | -33.33% | Disposed | (price as of 2026-10-02) |
| July 12, 2024 | ZTS | A | 140 | $57.53 | $8,054 | 166 Direct | +538.46% | Acquired | 21.1% (price as of 2026-10-02) |
| April 5, 2024 | ZTS | A | 25 | $53.31 | $1,333 | 25 Direct | · | Acquired | 30.7% (price as of 2026-10-02) |
| Feb. 6, 2024 | ZTS | A | 1,433 | · | · | 1,433 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 6, 2024 | ZTS | A | 5,514 | · | · | 5,514 Direct | · | Acquired | (price as of 2026-10-02) |
| July 31, 2023 | ZTS | A | 2,658 | · | · | 2,658 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 5, 2026 | MRNA | Restricted Stock Units | Common Stock | · | · | 38,364 | Acquired |
| July 5, 2026 | MRNA | Stock Option (Right to Buy) | Common Stock | $79.76 | July 5, 2036 | 18,658 | Acquired |
| Oct. 4, 2024 | ZTS | Phantom Stock Unit [F1] | Common Stock | · | · | 154 | Acquired |
| July 31, 2024 | ZTS | Restricted Stock Unit [F2] | Common Stock | · | · | 895 | Disposed |
| July 12, 2024 | ZTS | Phantom Stock Unit [F1] | Common Stock | · | · | 140 | Acquired |
| April 5, 2024 | ZTS | Phantom Stock Unit [F1] | Common Stock | · | · | 25 | Acquired |
| Feb. 6, 2024 | ZTS | Restricted Stock Unit [F1] | Common Stock | · | · | 1,433 | Acquired |
| Feb. 6, 2024 | ZTS | Stock Option [F6] | Common Stock | $196.14 | · | 5,514 | Acquired |
| July 31, 2023 | ZTS | Restricted Stock Unit [F1] | Common Stock | · | · | 2,658 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).